NEUCA S.A. (WSE:NEU)

Market Cap	3.38B +2.0%
Revenue (ttm)	13.83B +8.0%
Net Income	175.55M +20.1%
EPS	38.31 +19.1%
Shares Out	4.51M
PE Ratio	19.58
Forward PE	16.85
Dividend	17.80 (2.35%)
Ex-Dividend Date	Jun 29, 2026

Volume	219
Open	758.00
Previous Close	750.00
Day's Range	748.00 - 758.00
52-Week Range	645.00 - 857.00
Beta	0.43
Analysts	Strong Buy
Price Target	905.25 (+21.02%)
Earnings Date	May 21, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 5,339
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2025, NEUCA's revenue was 13.64 billion, an increase of 8.18% compared to the previous year's 12.61 billion. Earnings were 155.58 million, an increase of 0.87%.